Categories AlphaGraphs, Earnings, Health Care
JNJ Earnings: All you need to know about Johnson & Johnson’s Q4 2024 earnings results
Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2024 earnings results today.
Reported sales increased 5.3% year-over-year to $22.5 billion. Operational sales growth was 6.7%.

Net earnings decreased 17% to $3.4 billion, or $1.41 per share, compared to last year. Adjusted EPS decreased 10.9% to $2.04.
Revenue surpassed projections while earnings came in line with estimates.
For full-year 2025, the company expects reported sales of $89.2-90.0 billion and adjusted EPS of $10.50-10.70.
The stock stayed red in premarket hours on Wednesday.
Prior performance

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Infographic: Amazon (AMZN) Q4 2024 earnings beat estimates; sales rise 10%
E-commerce giant Amazon.com Inc. (NASDAQ: AMZN) on Thursday reported higher sales and profit for the fourth quarter of 2024. Earnings also beat analysts' estimates. Net sales increased to $187.8 billion
Philip Morris (PM) delivers strong performance in 4Q24 helped by smoke-free strength
Shares of Philip Morris International Inc. (NYSE: PM) jumped 10% on Thursday after the company delivered better-than-expected earnings results for the fourth quarter of 2024 and provided an encouraging outlook
Highlights of Bristol-Myers Squibb’s Q4 2024 earnings report
Biotechnology company Bristol Myers Squibb (NYSE: BMY) reported lower profit for the fourth quarter of 2024, despite an increase in revenue. Net income attributable to shareholders was $72 million or